Additionally, when using Kaplan–Meier survival analysis, it became clear that higher levels of CDCA3 and UBE2C together were linked to poorer survival outcomes for patients, regardless of the stage of the tumor or how advanced the tumor appeared under the microscope.46 This evidence concerns the gene UBE2C and neoplasm.